DLP-202 – hGH 3 month Formulation

DLP-202 is a system capable of delivering therapeutic levels of human growth hormone for 3 months. The product is using Delpor’s NANOPORTM technology enabling the sustained zero order release of the medication through constrained diffusion. The medication is released from Delpor’s subcutaneous implant device.

Comments are closed.